Latde Diagnostics
PrivateLast Round
Grant
Jul 1, 2025
Total Funding Raised
$2.35M
Company Overview
Latde Diagnostics is a life sciences company that develops rapid, instrument-free diagnostic tools for bacterial infections and antibiotic susceptibility profiling.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Latde Diagnostics Comparables
Compare Latde Diagnostics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| UTIlizer AB | 85% | |
| Microplate Dx | 84% | |
| Module Innovations | 83% |
Latde Diagnostics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jul 1, 2025 | ||||
| Grant | Jul 8, 2024 | ||||
| Seed | Jun 1, 2024 | ||||
| Grant | Mar 1, 2024 | ||||
| Grant | Jan 20, 2022 |
Latde Diagnostics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Institute of Allergy and Infectious Diseases | Grant |
| Massachusetts Development Finance Agency | Grant |
| MassVentures | Grant |
| Maroon Venture Partners | Seed |
| Public Health Emergency Medical Countermeasures Enterprise | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors increased 821% MoM.
- Jul 1, 2025
$30K grant received from Public Health Emergency Medical Countermeasures Enterprise.
Latde Diagnostics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Latde Diagnostics's valuation, stock price, and market status.
Is Latde Diagnostics a public or private company?
Latde Diagnostics is a private company.
What is the current stock price of Latde Diagnostics?
Latde Diagnostics is a private company with no public stock price. Caplight tracks Latde Diagnostics's secondary market activity and provides MarketPrice™ estimates to Caplight users.
How much is Latde Diagnostics worth (valuation)?
Valuation information for Latde Diagnostics is not publicly available.
Can I buy Latde Diagnostics stock?
Latde Diagnostics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Latde Diagnostics's last funding round?
Latde Diagnostics's most recent funding round was Grant on July 1, 2025.
Who are the main investors in Latde Diagnostics?
Key investors in Latde Diagnostics include National Institute of Allergy and Infectious Diseases, Massachusetts Development Finance Agency, MassVentures, Maroon Venture Partners, Public Health Emergency Medical Countermeasures Enterprise.
Will Latde Diagnostics IPO soon?
No public IPO plans have been announced for Latde Diagnostics.
How can I track Latde Diagnostics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Latde Diagnostics's secondary market activity and sign up for updates.